Katherine Stueland is the Chief Executive Officer at GENEDX HOLDINGS CORP CLASS A, a leading company in the field of genetic testing and diagnostics. With a robust background in healthcare and life sciences, Stueland has been instrumental in steering GeneDx towards significant growth and innovation. Before joining GeneDx, she held various executive positions, including roles at Invitae Corporation and Genomic Health, where she honed her skills in strategic planning and operational management. At GeneDx, Stueland has been pivotal in expanding the company's reach and enhancing its service offerings. Under her leadership, GeneDx has successfully launched new genetic testing panels and improved its data analytics capabilities, thereby strengthening its position in the competitive genomics market. Her strategic vision has not only driven the company's financial performance but also fostered a culture of scientific excellence and patient-centric care. Stueland's achievements extend beyond her corporate role. She is a recognized thought leader in the genomics industry, frequently speaking at conferences and contributing to discussions on the future of personalized medicine. Her commitment to advancing genetic healthcare is evident in her efforts to make genetic testing more accessible and affordable. As CEO, Katherine Stueland continues to lead GeneDx with a focus on innovation, quality, and patient impact, solidifying its reputation as a pioneer in the field of genetic diagnostics.